The discovery could reshape how we study psychedelic compounds in nature and medicine
At West Virginia University (WVU), Corinne Hazel, an undergraduate major in environmental microbiology, examined morning glory plants for signs of protective chemicals. She wasn’t looking for new drugs or anything psychedelic. But nestled in the folds of a tiny seed coat was a hint of white fuzz.
That fuzz turned out to be a fungus that scientists had been seeking since the 1930s. And this included Albert Hofmann, the Swiss chemist who first synthesized LSD.
Hofmann offered the world LSD in the late 1930s by modifying a compound called lysergic acid, which he extracted from the ergot fungus Claviceps purpurea. That fungus grows on rye and other grains and is well-known for producing ergot alkaloids, a group of chemicals that can be toxic or medicinal depending on the dose.
Hofmann and others searched the plants for a fungus related to Claviceps purpurea, the rye-dwelling microbe that produces ergot alkaloids, a group of potent compounds with powerful biological effects. But for decades, that fungus remained a phantom.
Hazel found it almost by accident.
“We had a ton of plants lying around and they had these tiny little seed coats,” she said. “We noticed a little bit of fuzz in the seed coat. That was our fungus.”
With Panaccione’s guidance, Hazel extracted DNA from the fuzz and sent it for sequencing. The results confirmed what generations of chemists and botanists had only suspected: the morning glory harbored a previously unknown species of ergot-producing fungus.
“Sequencing a genome is a significant thing,” Panaccione said. “It’s amazing for a student.”